EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, OABI: Omniab Inc

07 Nov 25 15:59
LAST:

1.380

CHANGE:
 0.00		OPEN:
1.350		HIGH:
1.400		ASK:
0.000		VOLUME:
776.5K
CHG(%):
0.00		PREV:
1.380		LOW:
1.330		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.3701.4001.3301.380883.4K
06 Nov 251.4101.4601.3801.380453.3K
05 Nov 251.4401.4881.3001.425885.2K
04 Nov 251.4501.5201.4501.480366.3K
03 Nov 251.5401.5501.4601.480405.1K
31 Oct 251.4901.5601.4801.550435.1K
30 Oct 251.4701.5201.4701.4902.96M
29 Oct 251.5401.5601.4501.470585.9K
28 Oct 251.5801.6101.5401.550315.2K
27 Oct 251.6501.7491.5801.590279.8K

COMPANY PROFILE

Name:Omniab Inc
About:OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Sector:Healthcare
Industry:Biotechnology
Address:5980 Horton Street, EmeryVille, CA, United States, 94608
Website:https://www.omniab.com
CUSIP:68218J103
CIK:0001846253
ISIN:US68218J1034
FIGI:BBG011J3QM39

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.43 
Forward P/E:-3.97 
PEG Ratio:-0.16 
Price to Sales:9.69 
Price to Book:0.73 
Profit Margin:-2.76 
Operating Margin:-4.16 
Return on Assets:-0.14 
Return on Equity:-0.23 
EPS Ratio:-0.61 
Revenue:23.03M 
Shares:143.96M 
Market Cap:198.66M 

TECHNICAL INDICATORS

MA5:1.433.6%
MA10:1.487.2%
MA20:1.5713.6%
MA50:1.6016.1%
MA100:1.7526.8%
MA200:2.0548.9%
RSI14:19.30 
WPR14:-100.00 
MTM14:-0.28
ROC14:-0.17 
ATR:0.10 
Week High:1.5613.0%
Week Low:1.306.2%
Month High:1.9037.3%
Month Low:1.3048.9%
Year High:4.71241.3%
Year Low:1.2213.1%
Volatility:38.01